SCHEMBL25910170

SCHEMBL25910170

CC(C)Nc1ncc(-c2ccc3cc(Oc4ccnc(NC(=O)CO)c4)ccc3n2)c(=O)n1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 4/20 0.48
▸ PDGFRB P09619 4/20 0.48
▸ PDGFRA P16234 3/20 0.48
▸ LCK P06239 2/20 0.48
▸ KIT P10721 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ FLT3 P36888 1/20 0.48
▸ PTK6 Q13882 1/20 0.48
▸ BRAF P15056 10/20 0.40
▸ MAPK14 Q16539 2/20 0.37
▸ RIOK2 Q9BVS4 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ FLT1 P17948 1/20 0.36
▸ FLT4 P35916 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ P2RX3 P56373 1/20 0.36
▸ AXL P30530 1/20 0.35
▸ MERTK Q12866 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910169 0.94 CSF1R (0.48) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25909917 0.91 PDGFRB (0.52) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910551 0.90 CSF1R (0.49) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910403 0.89 CSF1R (0.48) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910042 0.88 CSF1R (0.49) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25912277 0.86 CSF1R (0.41) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910040 0.84 CSF1R (0.49) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25911790 0.83 CSF1R (0.53) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910028 0.83 CSF1R (0.53) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25913293 0.82 CSF1R (0.52) CSF1RPDGFRBPDGFRALCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback